Insights into angiotensin II receptor function through AT2 receptor knockout mice.
暂无分享,去创建一个
[1] F. Luft,et al. Nitric oxide synthase expression in AT2 receptor-deficient mice after DOCA-salt. , 2004, Kidney international.
[2] F. Luft,et al. Cardiac hypertrophy and fibrosis in chronic l-NAME-treated AT2 receptor-deficient mice , 2004, Journal of hypertension.
[3] D. Kass,et al. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.
[4] M. Wellner,et al. Pressure natriuresis in AT(2) receptor-deficient mice with L-NAME hypertension. , 2003, Journal of the American Society of Nephrology : JASN.
[5] R. Freeman,et al. Angiotensin II's Antiproliferative Effects Mediated Through AT2-Receptors Depend On Down-Regulation of SM-20 , 2002, Laboratory Investigation.
[6] A. Diedrich,et al. Heart Rate Variability and Baroreflex Function in AT2 Receptor-Disrupted Mice , 2002, Hypertension.
[7] R. Stevenson,et al. AGTR2 Mutations in X-Linked Mental Retardation , 2002, Science.
[8] T. Ichiki,et al. Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension , 2001, Circulation.
[9] J. Blanco,et al. Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-κB and AP-1 in the Kidney : Role of AT1 and AT2 Receptors , 2001 .
[10] T. Walther,et al. Left ventricular function in mice lacking the AT2 receptor , 2001, Journal of hypertension.
[11] F. Gaffney,et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. , 2000, The Journal of clinical investigation.
[12] R. Plehm,et al. Long‐term blood pressure telemetry in AT2 receptor‐disrupted mice , 2000, Journal of hypertension.
[13] J. Sadoshima. Cytokine actions of angiotensin II. , 2000, Circulation research.
[14] T. Walther,et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. , 2000, Kidney international.
[15] J. Polak,et al. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. , 1999, Journal of the American Society of Nephrology : JASN.
[16] R. Carey,et al. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Ichiki,et al. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. , 1999, Biochemical and biophysical research communications.
[18] Y. Mori,et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. , 1998, The Journal of clinical investigation.
[19] A. Danser,et al. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. , 1997, Journal of molecular and cellular cardiology.
[20] B. Lévy,et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. , 1996, The Journal of clinical investigation.
[21] B. Hogan,et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor , 1995, Nature.
[22] Brian K. Kobilka,et al. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice , 1995, Nature.
[23] P. Timmermans,et al. Proposed update of angiotensin receptor nomenclature. , 1995, Hypertension.
[24] H. Inui,et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. , 1993, The Journal of biological chemistry.